Acadia Pharmaceuticals (ACAD) PT Raised to $54 at Jefferies
Tweet
Share
E-mailGet Alerts ACAD Hot Sheet
Price: $28.24 --0%
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 17
Rating Summary:
17 Buy, 10 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 17
Join SI Premium – FREE
Jefferies analyst Chris Howerton raised the price target on Acadia Pharmaceuticals (NASDAQ: ACAD) to $54.00 (from $53.00) while maintaining a Buy rating.
You May Also Be Interested In
- Acadia Pharmaceuticals (ACAD) PT Raised to $49 at UBS
- ArriVent BioPharma (AVBP) PT Raised to $47 at H.C. Wainwright
- JBS SA (JBS) PT Lowered to $17 at Stephens
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
